Gene Symbol | Gene ID | Gene Info |
---|---|---|
KLF8
|
ENSG00000102349.10 | Kruppel like factor 8 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chrX_56258780_56259711 | KLF8 | 235 | 0.963681 | 0.41 | 2.7e-01 | Click! |
chrX_56259756_56259980 | KLF8 | 388 | 0.924077 | 0.30 | 4.2e-01 | Click! |
chrX_56258114_56258265 | KLF8 | 681 | 0.822036 | 0.29 | 4.5e-01 | Click! |
chrX_56260062_56260213 | KLF8 | 657 | 0.831039 | 0.23 | 5.5e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr16_50714281_50714981 | 1.21 |
SNX20 |
sorting nexin 20 |
592 |
0.64 |
chr19_2041550_2041783 | 1.19 |
MKNK2 |
MAP kinase interacting serine/threonine kinase 2 |
415 |
0.72 |
chr16_29675034_29675898 | 1.19 |
QPRT |
quinolinate phosphoribosyltransferase |
866 |
0.35 |
chr12_6554644_6554853 | 1.15 |
CD27 |
CD27 molecule |
715 |
0.48 |
chr16_28997019_28997515 | 1.11 |
LAT |
linker for activation of T cells |
266 |
0.8 |
chr1_225654970_225655492 | 1.05 |
RP11-496N12.6 |
|
2186 |
0.34 |
chr22_20783754_20784060 | 0.92 |
SCARF2 |
scavenger receptor class F, member 2 |
8205 |
0.11 |
chrY_1726497_1727385 | 0.92 |
ENSG00000251841 |
. |
925849 |
0.0 |
chr19_49362125_49362344 | 0.87 |
PLEKHA4 |
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 4 |
397 |
0.71 |
chrX_1776580_1777384 | 0.86 |
ASMT |
acetylserotonin O-methyltransferase |
21691 |
0.23 |
chr16_27413508_27414237 | 0.85 |
IL21R |
interleukin 21 receptor |
377 |
0.88 |
chr21_46348074_46348493 | 0.85 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
350 |
0.75 |
chr14_91882732_91883366 | 0.85 |
CCDC88C |
coiled-coil domain containing 88C |
641 |
0.78 |
chr19_1258842_1259341 | 0.83 |
CIRBP |
cold inducible RNA binding protein |
293 |
0.78 |
chr15_40599321_40599893 | 0.82 |
PLCB2 |
phospholipase C, beta 2 |
419 |
0.68 |
chr19_3180678_3181240 | 0.81 |
S1PR4 |
sphingosine-1-phosphate receptor 4 |
2223 |
0.2 |
chr1_1564774_1565122 | 0.81 |
MIB2 |
mindbomb E3 ubiquitin protein ligase 2 |
1079 |
0.29 |
chr19_1074414_1074782 | 0.79 |
HMHA1 |
histocompatibility (minor) HA-1 |
2844 |
0.13 |
chr11_2322055_2322323 | 0.78 |
C11orf21 |
chromosome 11 open reading frame 21 |
954 |
0.34 |
chr12_53600321_53600967 | 0.78 |
ITGB7 |
integrin, beta 7 |
356 |
0.78 |
chr12_122075303_122075715 | 0.78 |
ORAI1 |
ORAI calcium release-activated calcium modulator 1 |
10788 |
0.17 |
chr19_6481304_6482171 | 0.77 |
DENND1C |
DENN/MADD domain containing 1C |
27 |
0.95 |
chr2_241976242_241976491 | 0.77 |
SNED1 |
sushi, nidogen and EGF-like domains 1 |
271 |
0.88 |
chr17_43326081_43326290 | 0.77 |
CTD-2020K17.4 |
|
18 |
0.93 |
chr3_50647795_50648029 | 0.76 |
CISH |
cytokine inducible SH2-containing protein |
1291 |
0.31 |
chr11_413234_413456 | 0.76 |
SIGIRR |
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
1603 |
0.21 |
chr19_39056366_39056550 | 0.75 |
RYR1 |
ryanodine receptor 1 (skeletal) |
1109 |
0.38 |
chr20_62369505_62369786 | 0.74 |
RP4-583P15.14 |
|
22 |
0.92 |
chrX_129220262_129220541 | 0.73 |
ELF4 |
E74-like factor 4 (ets domain transcription factor) |
23935 |
0.18 |
chr5_1105065_1105874 | 0.73 |
SLC12A7 |
solute carrier family 12 (potassium/chloride transporter), member 7 |
6681 |
0.19 |
chr17_74136403_74136800 | 0.72 |
RNF157-AS1 |
RNF157 antisense RNA 1 |
36 |
0.93 |
chr22_39639321_39639607 | 0.71 |
PDGFB |
platelet-derived growth factor beta polypeptide |
443 |
0.78 |
chr22_30662463_30662771 | 0.71 |
OSM |
oncostatin M |
211 |
0.88 |
chr6_31543406_31543804 | 0.71 |
TNF |
tumor necrosis factor |
261 |
0.72 |
chr17_42083610_42084286 | 0.70 |
NAGS |
N-acetylglutamate synthase |
1823 |
0.19 |
chr10_135089211_135089472 | 0.70 |
ADAM8 |
ADAM metallopeptidase domain 8 |
1013 |
0.36 |
chr20_62368079_62368369 | 0.69 |
LIME1 |
Lck interacting transmembrane adaptor 1 |
229 |
0.81 |
chr20_62272433_62273064 | 0.69 |
STMN3 |
stathmin-like 3 |
11371 |
0.09 |
chr17_2700217_2700494 | 0.69 |
RAP1GAP2 |
RAP1 GTPase activating protein 2 |
579 |
0.74 |
chr17_76254452_76254830 | 0.69 |
TMEM235 |
transmembrane protein 235 |
26519 |
0.12 |
chr10_51502200_51502361 | 0.68 |
AGAP7 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 7 |
15953 |
0.19 |
chr5_544016_544540 | 0.68 |
ENSG00000264233 |
. |
8281 |
0.14 |
chr16_745762_746190 | 0.68 |
FBXL16 |
F-box and leucine-rich repeat protein 16 |
49 |
0.9 |
chr19_49838375_49839003 | 0.68 |
CD37 |
CD37 molecule |
5 |
0.95 |
chr9_123687972_123688123 | 0.67 |
TRAF1 |
TNF receptor-associated factor 1 |
3000 |
0.29 |
chr11_67171589_67172183 | 0.67 |
TBC1D10C |
TBC1 domain family, member 10C |
226 |
0.8 |
chr7_1978940_1979381 | 0.67 |
MAD1L1 |
MAD1 mitotic arrest deficient-like 1 (yeast) |
1025 |
0.64 |
chr1_202129278_202129681 | 0.67 |
PTPN7 |
protein tyrosine phosphatase, non-receptor type 7 |
251 |
0.89 |
chr8_134086953_134087155 | 0.67 |
SLA |
Src-like-adaptor |
14451 |
0.23 |
chr1_26644827_26645344 | 0.67 |
UBXN11 |
UBX domain protein 11 |
231 |
0.76 |
chr1_9030857_9031244 | 0.66 |
ENSG00000265141 |
. |
8883 |
0.16 |
chr5_176784926_176785308 | 0.66 |
RGS14 |
regulator of G-protein signaling 14 |
279 |
0.82 |
chr1_2347262_2347748 | 0.66 |
PEX10 |
peroxisomal biogenesis factor 10 |
2269 |
0.17 |
chr1_1148809_1149188 | 0.66 |
TNFRSF4 |
tumor necrosis factor receptor superfamily, member 4 |
514 |
0.56 |
chr20_62199468_62200014 | 0.65 |
HELZ2 |
helicase with zinc finger 2, transcriptional coactivator |
314 |
0.8 |
chr7_2550958_2551215 | 0.64 |
LFNG |
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
1077 |
0.47 |
chr1_43397747_43398281 | 0.64 |
SLC2A1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
1218 |
0.47 |
chrX_19817156_19817441 | 0.63 |
SH3KBP1 |
SH3-domain kinase binding protein 1 |
571 |
0.85 |
chr17_29835728_29836211 | 0.63 |
ENSG00000264862 |
. |
9481 |
0.13 |
chr17_37309328_37309628 | 0.62 |
PLXDC1 |
plexin domain containing 1 |
7 |
0.97 |
chr7_150264558_150265605 | 0.62 |
GIMAP4 |
GTPase, IMAP family member 4 |
557 |
0.78 |
chr9_137288293_137289070 | 0.62 |
RXRA |
retinoid X receptor, alpha |
9747 |
0.23 |
chr16_27415626_27415898 | 0.62 |
IL21R |
interleukin 21 receptor |
1339 |
0.47 |
chr1_161038546_161039545 | 0.61 |
ARHGAP30 |
Rho GTPase activating protein 30 |
411 |
0.65 |
chr6_157040706_157041141 | 0.61 |
ARID1B |
AT rich interactive domain 1B (SWI1-like) |
58140 |
0.13 |
chr1_154981837_154981988 | 0.61 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
5012 |
0.08 |
chr9_131998413_131998748 | 0.61 |
ENSG00000220992 |
. |
5584 |
0.18 |
chr19_3136242_3137376 | 0.61 |
GNA15 |
guanine nucleotide binding protein (G protein), alpha 15 (Gq class) |
618 |
0.58 |
chr22_39639623_39639926 | 0.60 |
PDGFB |
platelet-derived growth factor beta polypeptide |
753 |
0.58 |
chr8_134070506_134071129 | 0.60 |
SLA |
Src-like-adaptor |
1786 |
0.44 |
chr12_7061251_7061427 | 0.59 |
PTPN6 |
protein tyrosine phosphatase, non-receptor type 6 |
801 |
0.31 |
chr6_35265630_35266434 | 0.59 |
DEF6 |
differentially expressed in FDCP 6 homolog (mouse) |
403 |
0.84 |
chr17_53341326_53341539 | 0.59 |
HLF |
hepatic leukemia factor |
941 |
0.65 |
chr2_127838515_127838718 | 0.59 |
BIN1 |
bridging integrator 1 |
25961 |
0.21 |
chr20_62271176_62271486 | 0.59 |
CTD-3184A7.4 |
|
12728 |
0.09 |
chr20_4795121_4795462 | 0.59 |
RASSF2 |
Ras association (RalGDS/AF-6) domain family member 2 |
478 |
0.82 |
chr21_46348831_46348982 | 0.59 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
118 |
0.91 |
chr9_95727676_95727827 | 0.59 |
FGD3 |
FYVE, RhoGEF and PH domain containing 3 |
1508 |
0.45 |
chr1_209943452_209943666 | 0.59 |
TRAF3IP3 |
TRAF3 interacting protein 3 |
1599 |
0.29 |
chr17_76123581_76124282 | 0.59 |
TMC6 |
transmembrane channel-like 6 |
780 |
0.49 |
chr17_2718119_2718351 | 0.58 |
RAP1GAP2 |
RAP1 GTPase activating protein 2 |
18459 |
0.17 |
chr7_150148744_150149359 | 0.58 |
GIMAP8 |
GTPase, IMAP family member 8 |
1333 |
0.41 |
chr13_99222825_99223522 | 0.58 |
STK24 |
serine/threonine kinase 24 |
5944 |
0.22 |
chr10_47639246_47639397 | 0.58 |
ANTXRLP1 |
anthrax toxin receptor-like pseudogene 1 |
5470 |
0.23 |
chr20_47436352_47436503 | 0.58 |
PREX1 |
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 |
7993 |
0.28 |
chr2_5768317_5769063 | 0.58 |
AC108025.2 |
|
62488 |
0.12 |
chr1_248644857_248645289 | 0.57 |
RP11-407H12.8 |
|
3712 |
0.13 |
chrY_2802917_2803120 | 0.57 |
ZFY |
zinc finger protein, Y-linked |
94 |
0.98 |
chr17_76126911_76127107 | 0.57 |
TMC8 |
transmembrane channel-like 8 |
140 |
0.63 |
chr14_23425532_23426266 | 0.57 |
HAUS4 |
HAUS augmin-like complex, subunit 4 |
332 |
0.43 |
chr4_7972052_7972961 | 0.57 |
AFAP1 |
actin filament associated protein 1 |
30853 |
0.14 |
chr8_29356447_29357119 | 0.56 |
RP4-676L2.1 |
|
146096 |
0.04 |
chr17_76129934_76130268 | 0.56 |
TMC6 |
transmembrane channel-like 6 |
1613 |
0.24 |
chr5_176785343_176785607 | 0.56 |
RGS14 |
regulator of G-protein signaling 14 |
637 |
0.54 |
chr1_6086479_6086932 | 0.56 |
KCNAB2 |
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
325 |
0.88 |
chr13_114905676_114905991 | 0.56 |
RASA3 |
RAS p21 protein activator 3 |
7747 |
0.23 |
chr3_13919959_13920372 | 0.56 |
WNT7A |
wingless-type MMTV integration site family, member 7A |
1453 |
0.48 |
chr12_121678452_121678939 | 0.55 |
CAMKK2 |
calcium/calmodulin-dependent protein kinase kinase 2, beta |
19650 |
0.17 |
chr21_46340224_46340398 | 0.55 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
459 |
0.52 |
chr7_150212054_150212338 | 0.55 |
GIMAP7 |
GTPase, IMAP family member 7 |
278 |
0.91 |
chr17_29836291_29836532 | 0.55 |
ENSG00000264862 |
. |
9039 |
0.13 |
chr16_68113033_68113320 | 0.55 |
NFATC3 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
6071 |
0.11 |
chr16_2390815_2390992 | 0.55 |
ABCA3 |
ATP-binding cassette, sub-family A (ABC1), member 3 |
156 |
0.92 |
chr17_55162734_55163425 | 0.54 |
AKAP1 |
A kinase (PRKA) anchor protein 1 |
1 |
0.98 |
chr17_43300498_43300952 | 0.54 |
CTD-2020K17.1 |
|
1136 |
0.27 |
chr4_143322143_143322556 | 0.54 |
INPP4B |
inositol polyphosphate-4-phosphatase, type II, 105kDa |
30063 |
0.27 |
chr11_67174361_67174809 | 0.54 |
TBC1D10C |
TBC1 domain family, member 10C |
2925 |
0.09 |
chr9_95570477_95570696 | 0.54 |
ANKRD19P |
ankyrin repeat domain 19, pseudogene |
1307 |
0.42 |
chr12_113541770_113542011 | 0.54 |
RASAL1 |
RAS protein activator like 1 (GAP1 like) |
31419 |
0.11 |
chr17_4389201_4389708 | 0.54 |
RP13-580F15.2 |
|
194 |
0.92 |
chr16_3117341_3117492 | 0.54 |
IL32 |
interleukin 32 |
1603 |
0.13 |
chr13_75900164_75900519 | 0.54 |
TBC1D4 |
TBC1 domain family, member 4 |
15326 |
0.24 |
chr22_39147328_39147855 | 0.54 |
SUN2 |
Sad1 and UNC84 domain containing 2 |
1272 |
0.23 |
chrX_15756367_15757484 | 0.54 |
CA5B |
carbonic anhydrase VB, mitochondrial |
532 |
0.77 |
chr1_206732155_206732306 | 0.54 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
1737 |
0.33 |
chr16_3014050_3014451 | 0.54 |
KREMEN2 |
kringle containing transmembrane protein 2 |
26 |
0.93 |
chr11_64511299_64511931 | 0.53 |
RASGRP2 |
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
2 |
0.96 |
chr8_21917643_21917901 | 0.53 |
DMTN |
dematin actin binding protein |
1038 |
0.39 |
chr2_242556723_242557374 | 0.53 |
THAP4 |
THAP domain containing 4 |
132 |
0.94 |
chr22_42177525_42177912 | 0.53 |
MEI1 |
meiosis inhibitor 1 |
21 |
0.96 |
chr11_127906960_127907260 | 0.53 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
468179 |
0.01 |
chr22_25003667_25003833 | 0.53 |
GGT1 |
gamma-glutamyltransferase 1 |
119 |
0.95 |
chr15_80262648_80263745 | 0.53 |
BCL2A1 |
BCL2-related protein A1 |
315 |
0.89 |
chrX_48774787_48775443 | 0.53 |
PIM2 |
pim-2 oncogene |
1186 |
0.29 |
chr20_62368373_62368670 | 0.53 |
LIME1 |
Lck interacting transmembrane adaptor 1 |
116 |
0.89 |
chr17_43325815_43326080 | 0.52 |
CTD-2020K17.4 |
|
241 |
0.73 |
chrX_48776964_48777355 | 0.52 |
PIM2 |
pim-2 oncogene |
858 |
0.41 |
chr1_158900461_158900612 | 0.52 |
PYHIN1 |
pyrin and HIN domain family, member 1 |
50 |
0.98 |
chr16_50300498_50301073 | 0.52 |
ADCY7 |
adenylate cyclase 7 |
323 |
0.9 |
chr11_414426_414987 | 0.52 |
SIGIRR |
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
242 |
0.84 |
chr19_39368986_39369494 | 0.52 |
RINL |
Ras and Rab interactor-like |
321 |
0.74 |
chr6_170403243_170403627 | 0.52 |
RP11-302L19.1 |
|
74306 |
0.11 |
chr19_36394196_36394709 | 0.52 |
HCST |
hematopoietic cell signal transducer |
1012 |
0.27 |
chr17_75451037_75451416 | 0.52 |
SEPT9 |
septin 9 |
1064 |
0.46 |
chr22_24824195_24824560 | 0.52 |
ADORA2A |
adenosine A2a receptor |
847 |
0.61 |
chr2_233925739_233925978 | 0.52 |
INPP5D |
inositol polyphosphate-5-phosphatase, 145kDa |
669 |
0.7 |
chr19_40971994_40972433 | 0.52 |
SPTBN4 |
spectrin, beta, non-erythrocytic 4 |
65 |
0.86 |
chr19_2620421_2620723 | 0.52 |
CTC-265F19.2 |
|
8712 |
0.14 |
chr19_2082409_2082561 | 0.51 |
MOB3A |
MOB kinase activator 3A |
2906 |
0.15 |
chr14_22966536_22967037 | 0.51 |
TRAJ51 |
T cell receptor alpha joining 51 (pseudogene) |
10615 |
0.1 |
chr11_35164510_35164661 | 0.51 |
CD44 |
CD44 molecule (Indian blood group) |
3732 |
0.2 |
chr3_13921820_13922148 | 0.51 |
WNT7A |
wingless-type MMTV integration site family, member 7A |
366 |
0.9 |
chr3_32995983_32996275 | 0.51 |
CCR4 |
chemokine (C-C motif) receptor 4 |
3063 |
0.34 |
chr1_154980554_154980872 | 0.51 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
5418 |
0.08 |
chr12_7061050_7061251 | 0.51 |
PTPN6 |
protein tyrosine phosphatase, non-receptor type 6 |
612 |
0.41 |
chr10_82219062_82219764 | 0.51 |
TSPAN14 |
tetraspanin 14 |
355 |
0.89 |
chr11_75063141_75063646 | 0.51 |
ARRB1 |
arrestin, beta 1 |
520 |
0.72 |
chr1_201709300_201709781 | 0.51 |
NAV1 |
neuron navigator 1 |
544 |
0.66 |
chr22_19879311_19879851 | 0.51 |
GNB1L |
guanine nucleotide binding protein (G protein), beta polypeptide 1-like |
37119 |
0.1 |
chr1_207088744_207089040 | 0.51 |
FAIM3 |
Fas apoptotic inhibitory molecule 3 |
6320 |
0.15 |
chr10_73847731_73848399 | 0.50 |
SPOCK2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
21 |
0.98 |
chr11_2466894_2467127 | 0.50 |
KCNQ1 |
potassium voltage-gated channel, KQT-like subfamily, member 1 |
789 |
0.56 |
chr19_15574852_15575181 | 0.50 |
RASAL3 |
RAS protein activator like 3 |
366 |
0.8 |
chr7_37487305_37488000 | 0.50 |
ELMO1 |
engulfment and cell motility 1 |
901 |
0.61 |
chr11_73692681_73692970 | 0.50 |
UCP2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
842 |
0.53 |
chr11_66885722_66885917 | 0.50 |
KDM2A |
lysine (K)-specific demethylase 2A |
921 |
0.56 |
chr3_42544302_42544877 | 0.50 |
VIPR1 |
vasoactive intestinal peptide receptor 1 |
474 |
0.79 |
chr11_121322202_121322467 | 0.50 |
SORL1 |
sortilin-related receptor, L(DLR class) A repeats containing |
578 |
0.7 |
chr19_7415020_7415240 | 0.50 |
CTB-133G6.1 |
|
1282 |
0.4 |
chr4_40195304_40195587 | 0.50 |
RHOH |
ras homolog family member H |
162 |
0.96 |
chrX_128917010_128917187 | 0.50 |
SASH3 |
SAM and SH3 domain containing 3 |
3138 |
0.26 |
chr7_128579388_128579603 | 0.50 |
IRF5 |
interferon regulatory factor 5 |
765 |
0.6 |
chr4_148982006_148982383 | 0.50 |
RP11-76G10.1 |
|
85428 |
0.1 |
chr4_8201623_8202091 | 0.50 |
SH3TC1 |
SH3 domain and tetratricopeptide repeats 1 |
759 |
0.71 |
chr8_8202203_8202575 | 0.50 |
SGK223 |
Tyrosine-protein kinase SgK223 |
36868 |
0.18 |
chr22_25003998_25004507 | 0.50 |
GGT1 |
gamma-glutamyltransferase 1 |
621 |
0.67 |
chr19_3180285_3180457 | 0.49 |
S1PR4 |
sphingosine-1-phosphate receptor 4 |
1635 |
0.26 |
chr13_50698385_50698672 | 0.49 |
DLEU1 |
deleted in lymphocytic leukemia 1 (non-protein coding) |
42221 |
0.15 |
chr21_42798492_42799079 | 0.49 |
MX1 |
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) |
617 |
0.73 |
chr2_231090336_231091061 | 0.49 |
SP140 |
SP140 nuclear body protein |
219 |
0.54 |
chr19_40170310_40170461 | 0.49 |
LGALS17A |
|
371 |
0.79 |
chr13_100027611_100027771 | 0.49 |
ENSG00000207719 |
. |
19306 |
0.2 |
chr16_1047518_1048062 | 0.49 |
SOX8 |
SRY (sex determining region Y)-box 8 |
15982 |
0.12 |
chr9_135117163_135117384 | 0.49 |
ENSG00000221105 |
. |
27011 |
0.2 |
chr17_38720511_38720770 | 0.49 |
CCR7 |
chemokine (C-C motif) receptor 7 |
1071 |
0.49 |
chr8_27183037_27183778 | 0.49 |
PTK2B |
protein tyrosine kinase 2 beta |
326 |
0.9 |
chr9_95823599_95823812 | 0.49 |
SUSD3 |
sushi domain containing 3 |
2644 |
0.25 |
chr11_65313728_65314148 | 0.49 |
LTBP3 |
latent transforming growth factor beta binding protein 3 |
292 |
0.8 |
chr5_35859258_35859647 | 0.49 |
IL7R |
interleukin 7 receptor |
2458 |
0.3 |
chr14_93117897_93118048 | 0.49 |
RIN3 |
Ras and Rab interactor 3 |
874 |
0.71 |
chr13_50810191_50810488 | 0.49 |
ENSG00000221198 |
. |
127034 |
0.05 |
chr19_49140164_49140638 | 0.49 |
DBP |
D site of albumin promoter (albumin D-box) binding protein |
219 |
0.83 |
chr22_39148225_39148574 | 0.49 |
SUN2 |
Sad1 and UNC84 domain containing 2 |
2080 |
0.14 |
chr15_81591495_81592151 | 0.49 |
IL16 |
interleukin 16 |
66 |
0.98 |
chrX_13103844_13104411 | 0.49 |
FAM9C |
family with sequence similarity 9, member C |
41326 |
0.19 |
chr2_102844241_102844460 | 0.49 |
IL1RL2 |
interleukin 1 receptor-like 2 |
40576 |
0.14 |
chr5_139125915_139126675 | 0.48 |
ENSG00000200756 |
. |
28620 |
0.17 |
chr7_129420283_129420683 | 0.48 |
ENSG00000207691 |
. |
5629 |
0.16 |
chr14_76009252_76009829 | 0.48 |
BATF |
basic leucine zipper transcription factor, ATF-like |
20637 |
0.15 |
chr11_1873160_1873311 | 0.48 |
LSP1 |
lymphocyte-specific protein 1 |
965 |
0.36 |
chr22_37881738_37882044 | 0.48 |
MFNG |
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
534 |
0.71 |
chr3_52086298_52086652 | 0.48 |
DUSP7 |
dual specificity phosphatase 7 |
3706 |
0.15 |
chr17_54672260_54672411 | 0.48 |
NOG |
noggin |
1275 |
0.61 |
chr11_67250873_67251362 | 0.48 |
AIP |
aryl hydrocarbon receptor interacting protein |
605 |
0.49 |
chr2_241975771_241976142 | 0.48 |
SNED1 |
sushi, nidogen and EGF-like domains 1 |
681 |
0.61 |
chr7_38389675_38390189 | 0.48 |
AMPH |
amphiphysin |
112781 |
0.07 |
chr1_101703704_101704393 | 0.48 |
S1PR1 |
sphingosine-1-phosphate receptor 1 |
1604 |
0.28 |
chr1_200991644_200992373 | 0.48 |
KIF21B |
kinesin family member 21B |
528 |
0.78 |
chr11_65408534_65408946 | 0.48 |
SIPA1 |
signal-induced proliferation-associated 1 |
441 |
0.63 |
chr16_50776896_50777610 | 0.48 |
RP11-327F22.1 |
|
527 |
0.39 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.1 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.6 | 1.7 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.5 | 1.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.5 | 1.5 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.5 | 1.5 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.5 | 1.0 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.5 | 1.9 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.5 | 1.4 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.5 | 0.9 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.5 | 2.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.5 | 1.4 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.4 | 1.3 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.4 | 1.3 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.4 | 2.1 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.4 | 1.2 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.4 | 1.2 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.4 | 0.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.4 | 0.4 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.4 | 1.8 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.3 | 0.7 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
0.3 | 1.0 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.3 | 1.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 1.0 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
0.3 | 1.0 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 0.3 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.3 | 1.0 | GO:0051832 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.3 | 1.3 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.3 | 1.3 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.3 | 0.9 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.3 | 0.9 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.3 | 0.9 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.3 | 2.4 | GO:0007172 | signal complex assembly(GO:0007172) |
0.3 | 0.9 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.3 | 0.6 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.3 | 0.6 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.3 | 1.2 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.3 | 1.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.3 | 1.4 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.3 | 0.6 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.3 | 1.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.3 | 0.6 | GO:0001821 | histamine secretion(GO:0001821) |
0.3 | 0.8 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.3 | 0.3 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.3 | 0.5 | GO:1900120 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.3 | 0.8 | GO:0045056 | transcytosis(GO:0045056) |
0.3 | 0.8 | GO:0008049 | male courtship behavior(GO:0008049) |
0.3 | 0.5 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.3 | 1.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.3 | 2.4 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.3 | 1.3 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.3 | 1.0 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 0.8 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.3 | 1.3 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.3 | 0.8 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.3 | 1.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.2 | 1.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 1.2 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 0.7 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.2 | 0.2 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.2 | 0.7 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.2 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.7 | GO:0043368 | positive T cell selection(GO:0043368) |
0.2 | 1.9 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.2 | 0.2 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.2 | 0.2 | GO:0003171 | heart valve development(GO:0003170) atrioventricular valve development(GO:0003171) heart valve morphogenesis(GO:0003179) atrioventricular valve morphogenesis(GO:0003181) |
0.2 | 1.4 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 0.9 | GO:0050685 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.2 | 0.7 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 0.7 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.2 | 0.7 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.2 | 0.7 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 0.4 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.2 | 1.8 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.2 | 0.4 | GO:0048799 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.2 | 0.9 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.2 | 0.6 | GO:0002823 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.2 | 1.1 | GO:0002329 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.2 | 0.8 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 0.2 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
0.2 | 0.8 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.2 | 0.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 0.6 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.2 | 0.6 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 0.4 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.2 | 1.0 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 0.4 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 0.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.2 | 1.4 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.2 | 0.4 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.2 | 0.4 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.2 | 0.2 | GO:0050832 | defense response to fungus(GO:0050832) |
0.2 | 1.0 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.2 | 8.3 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.2 | 0.6 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 0.6 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.2 | 0.4 | GO:0010761 | fibroblast migration(GO:0010761) |
0.2 | 0.6 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 1.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.2 | 0.9 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 0.6 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 0.2 | GO:0051023 | immunoglobulin secretion(GO:0048305) regulation of immunoglobulin secretion(GO:0051023) |
0.2 | 0.5 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.2 | 0.5 | GO:0097205 | regulation of glomerular filtration(GO:0003093) glomerular filtration(GO:0003094) renal filtration(GO:0097205) regulation of renal system process(GO:0098801) |
0.2 | 0.4 | GO:0002707 | negative regulation of lymphocyte mediated immunity(GO:0002707) |
0.2 | 0.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 0.4 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.2 | 1.6 | GO:0051322 | anaphase(GO:0051322) |
0.2 | 0.5 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.2 | 0.5 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 0.7 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.2 | 0.3 | GO:1902745 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
0.2 | 0.3 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.2 | 0.8 | GO:0045350 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.2 | 0.7 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.2 | 1.0 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.2 | 0.3 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 0.5 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) layer formation in cerebral cortex(GO:0021819) telencephalon glial cell migration(GO:0022030) |
0.2 | 0.8 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 0.8 | GO:0070293 | renal absorption(GO:0070293) |
0.2 | 0.5 | GO:0010447 | response to acidic pH(GO:0010447) |
0.2 | 0.8 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.2 | 0.5 | GO:0002507 | tolerance induction(GO:0002507) |
0.2 | 0.7 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 0.2 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.2 | 0.2 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.2 | 2.0 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.2 | 2.2 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.2 | 1.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 0.6 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
0.2 | 0.2 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.2 | 1.6 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.2 | 7.4 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.2 | 0.5 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 0.3 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.2 | 0.8 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 1.4 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.2 | 1.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 0.5 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.2 | 0.5 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.2 | 0.5 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 0.5 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.2 | 0.3 | GO:0032898 | neurotrophin production(GO:0032898) |
0.1 | 1.3 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.4 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.1 | 0.9 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.1 | 0.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.4 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.1 | 0.4 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.3 | GO:0002540 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.1 | 0.9 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.1 | 0.6 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.4 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.1 | 0.6 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.4 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.1 | 0.4 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.1 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.1 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.1 | 0.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 6.6 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.1 | 0.7 | GO:0034311 | diol metabolic process(GO:0034311) |
0.1 | 0.7 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 1.3 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.1 | GO:1904019 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.1 | 0.1 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.1 | 0.3 | GO:0001743 | optic placode formation(GO:0001743) |
0.1 | 0.3 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.1 | 0.3 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.1 | 0.4 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.1 | 1.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.3 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 0.3 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 0.1 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.1 | 0.3 | GO:0035268 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.1 | 0.4 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.1 | 0.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.1 | 0.5 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.9 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.5 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.8 | GO:0002063 | chondrocyte development(GO:0002063) |
0.1 | 0.9 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
0.1 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.7 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.7 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.4 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.1 | 0.4 | GO:0072600 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.1 | 2.1 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 0.4 | GO:0031507 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.1 | 0.5 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.1 | 0.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.4 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 1.8 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.1 | 0.4 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.1 | 0.5 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.1 | 0.3 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 0.3 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.5 | GO:0071027 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 0.8 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 1.2 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.3 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.1 | 0.8 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.5 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.1 | 1.1 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.1 | 0.4 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.1 | 2.4 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.1 | 1.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.5 | GO:0046398 | UDP-glucuronate metabolic process(GO:0046398) |
0.1 | 0.4 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 0.6 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.4 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.4 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.1 | 0.2 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 0.4 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.4 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.4 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 1.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 1.5 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.2 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 1.6 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.1 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.2 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.1 | 0.4 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 2.6 | GO:0006997 | nucleus organization(GO:0006997) |
0.1 | 0.2 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.6 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.1 | 0.8 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.1 | 0.5 | GO:0034227 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.1 | 0.5 | GO:0002637 | regulation of immunoglobulin production(GO:0002637) |
0.1 | 0.5 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 0.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.2 | GO:0001705 | ectoderm formation(GO:0001705) |
0.1 | 1.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.5 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) |
0.1 | 0.2 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 0.2 | GO:0010822 | positive regulation of mitochondrion organization(GO:0010822) positive regulation of release of cytochrome c from mitochondria(GO:0090200) positive regulation of apoptotic signaling pathway(GO:2001235) |
0.1 | 0.3 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.3 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.2 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.4 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.3 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.1 | 0.6 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.1 | 0.3 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 0.1 | GO:0035844 | cloaca development(GO:0035844) cloacal septation(GO:0060197) |
0.1 | 0.1 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.1 | 0.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.2 | GO:0051459 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.3 | GO:0070570 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.1 | 0.1 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.1 | 0.4 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.1 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.1 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.1 | 0.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.2 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.1 | 0.4 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.4 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.1 | 0.3 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.1 | 0.3 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.1 | 0.1 | GO:0060558 | regulation of vitamin metabolic process(GO:0030656) vitamin D biosynthetic process(GO:0042368) regulation of vitamin D biosynthetic process(GO:0060556) regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
0.1 | 1.7 | GO:0030593 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
0.1 | 0.8 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.4 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.5 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.1 | 1.0 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 1.0 | GO:0000303 | response to superoxide(GO:0000303) |
0.1 | 0.1 | GO:2001259 | positive regulation of calcium ion transmembrane transporter activity(GO:1901021) positive regulation of cation channel activity(GO:2001259) |
0.1 | 0.2 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 0.7 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 1.0 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.1 | GO:0051383 | kinetochore organization(GO:0051383) |
0.1 | 0.1 | GO:0071426 | ribonucleoprotein complex export from nucleus(GO:0071426) |
0.1 | 0.5 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.4 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.3 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.9 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.4 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.6 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.1 | 1.4 | GO:1902583 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.1 | 0.6 | GO:1904377 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.1 | 0.3 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.1 | 0.1 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.1 | 0.1 | GO:0016241 | regulation of macroautophagy(GO:0016241) |
0.1 | 0.5 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.7 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.2 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.1 | 0.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.5 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.1 | 0.2 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.2 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.1 | 0.3 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.1 | 0.2 | GO:0032876 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.1 | 0.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.1 | 0.3 | GO:0045010 | actin nucleation(GO:0045010) |
0.1 | 0.3 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.1 | 0.2 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.1 | 0.3 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.2 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.1 | 0.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.5 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 0.2 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.1 | 0.5 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.8 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.3 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.2 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.7 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.3 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 0.9 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.3 | GO:0019348 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.2 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 1.3 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.3 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 0.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.3 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.1 | 0.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.3 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.1 | 0.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.2 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.7 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.3 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.1 | 0.1 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.9 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.2 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.1 | 0.6 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.1 | 0.3 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.8 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.1 | 1.2 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.3 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 0.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.3 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.6 | GO:0009209 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) pyrimidine ribonucleoside biosynthetic process(GO:0046132) |
0.1 | 0.3 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.3 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.1 | 0.2 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.6 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 1.8 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.4 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.5 | GO:0015851 | nucleobase transport(GO:0015851) |
0.1 | 0.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 3.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.2 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.1 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.1 | 0.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.5 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.1 | 0.9 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.1 | GO:0098754 | detoxification(GO:0098754) |
0.1 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 1.7 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.2 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.1 | GO:0010626 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.1 | 0.8 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.1 | 0.2 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.8 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.9 | GO:0034612 | response to tumor necrosis factor(GO:0034612) |
0.1 | 0.1 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.1 | 0.2 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 1.2 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.1 | 2.2 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.3 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.1 | 0.1 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.2 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 2.5 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.1 | 0.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.2 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.2 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.1 | 0.2 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.2 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.7 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 0.1 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.1 | 0.1 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.1 | 0.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.2 | GO:0002706 | regulation of lymphocyte mediated immunity(GO:0002706) |
0.1 | 3.6 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.1 | 0.1 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.1 | 0.8 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.1 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 1.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.1 | 0.9 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.2 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 1.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.1 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.1 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.1 | 0.4 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.5 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.3 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.1 | 0.1 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.2 | GO:0043276 | anoikis(GO:0043276) |
0.1 | 0.1 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.1 | 0.1 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.1 | 1.8 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.1 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.1 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.1 | 0.6 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.9 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.1 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.1 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.1 | 0.1 | GO:0090311 | regulation of protein deacetylation(GO:0090311) positive regulation of protein deacetylation(GO:0090312) |
0.1 | 0.2 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 0.1 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.1 | 0.2 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.1 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.1 | 0.1 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.1 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 0.2 | GO:0015825 | L-serine transport(GO:0015825) serine transport(GO:0032329) |
0.1 | 0.2 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.1 | 0.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 1.3 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.6 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 0.7 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.4 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 0.3 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.1 | 0.2 | GO:0097061 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.1 | 0.3 | GO:0032108 | negative regulation of response to food(GO:0032096) negative regulation of response to extracellular stimulus(GO:0032105) negative regulation of response to nutrient levels(GO:0032108) |
0.1 | 0.2 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.1 | 0.1 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.1 | 2.7 | GO:0007051 | spindle organization(GO:0007051) |
0.1 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.3 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.2 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.1 | 0.6 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 0.1 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.1 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.1 | 0.1 | GO:0050912 | detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.1 | 14.8 | GO:0016568 | chromatin modification(GO:0016568) |
0.1 | 0.2 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 0.3 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.4 | GO:0050684 | regulation of mRNA processing(GO:0050684) regulation of mRNA metabolic process(GO:1903311) |
0.1 | 0.3 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.1 | 0.3 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 0.8 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.2 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.1 | 2.6 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.1 | 1.0 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
0.1 | 0.6 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.3 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.1 | 0.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.1 | GO:0032392 | DNA geometric change(GO:0032392) |
0.1 | 0.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.8 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.1 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 0.1 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 1.5 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.2 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.1 | 0.1 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.1 | GO:0051299 | centrosome separation(GO:0051299) |
0.1 | 0.2 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.1 | 0.5 | GO:0019682 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.1 | 0.4 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.1 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.1 | 0.6 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.3 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.1 | 1.4 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.1 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.4 | GO:0072413 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.1 | 0.1 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.1 | 0.4 | GO:0031929 | TOR signaling(GO:0031929) |
0.1 | 0.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 2.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.5 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.1 | 0.1 | GO:0042117 | monocyte activation(GO:0042117) |
0.1 | 0.1 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.1 | 0.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 0.4 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.1 | 0.3 | GO:0051597 | response to methylmercury(GO:0051597) |
0.1 | 0.2 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 0.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.2 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.1 | 0.4 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.1 | 0.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 0.1 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.1 | 0.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.2 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.1 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.1 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.3 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 1.5 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.1 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.1 | 0.9 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.1 | 0.3 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.1 | 0.3 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.3 | GO:0045008 | depyrimidination(GO:0045008) |
0.1 | 0.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.1 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.1 | 0.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.1 | 0.8 | GO:0001906 | cell killing(GO:0001906) |
0.1 | 0.5 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.1 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.1 | 0.1 | GO:0009218 | pyrimidine ribonucleotide metabolic process(GO:0009218) pyrimidine ribonucleotide biosynthetic process(GO:0009220) |
0.1 | 0.1 | GO:0015919 | peroxisomal membrane transport(GO:0015919) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.2 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 1.5 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 0.4 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.1 | 0.2 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.1 | 0.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.7 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.3 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.1 | 0.2 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.1 | 0.2 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.1 | 0.1 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.1 | 4.0 | GO:0050657 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) establishment of RNA localization(GO:0051236) |
0.1 | 0.1 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.2 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.1 | 0.1 | GO:0014742 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.1 | 0.1 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.1 | 3.5 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.4 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.2 | GO:0090267 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 0.1 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.1 | 0.1 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 0.1 | GO:0042663 | endodermal cell fate specification(GO:0001714) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
0.1 | 0.1 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.1 | 0.1 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 0.1 | GO:0006473 | protein acetylation(GO:0006473) |
0.1 | 0.2 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 0.2 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.1 | 0.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.4 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.1 | 1.2 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.1 | 0.2 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.1 | 0.2 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.1 | 0.2 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 0.5 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.2 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.1 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 1.3 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.5 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.8 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.0 | 0.4 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 0.0 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.0 | 0.3 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.1 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.0 | 3.5 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.0 | 0.0 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.0 | 0.5 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 1.7 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 3.3 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.1 | GO:0006612 | protein targeting to membrane(GO:0006612) |
0.0 | 0.1 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.2 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.0 | 0.1 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.0 | 0.2 | GO:0006906 | vesicle fusion(GO:0006906) |
0.0 | 0.2 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.0 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.0 | 0.2 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.7 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.0 | 0.3 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.5 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 0.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.0 | 0.0 | GO:0043620 | mRNA transcription(GO:0009299) regulation of transcription from RNA polymerase II promoter in response to stress(GO:0043618) regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.0 | 0.0 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.0 | 0.1 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.1 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.0 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 1.4 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.0 | 0.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.3 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.4 | GO:0006302 | double-strand break repair(GO:0006302) |
0.0 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.3 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi vesicle budding(GO:0048194) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.0 | 0.4 | GO:1902099 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.0 | 0.1 | GO:0000239 | pachytene(GO:0000239) |
0.0 | 0.2 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.8 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.0 | 0.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.2 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.0 | 0.3 | GO:0035967 | cellular response to topologically incorrect protein(GO:0035967) |
0.0 | 0.0 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.0 | 0.2 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.3 | GO:0006818 | hydrogen transport(GO:0006818) |
0.0 | 1.6 | GO:0006165 | nucleoside diphosphate phosphorylation(GO:0006165) nucleotide phosphorylation(GO:0046939) |
0.0 | 0.1 | GO:1901798 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.0 | GO:0009304 | tRNA transcription(GO:0009304) |
0.0 | 0.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.1 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.2 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.7 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.0 | 0.1 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 0.1 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.0 | GO:0006573 | valine metabolic process(GO:0006573) |
0.0 | 0.1 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.1 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.0 | 0.4 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.0 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.0 | 0.2 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.0 | 0.1 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 0.2 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.0 | 0.1 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.0 | 0.1 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.0 | 0.1 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 3.1 | GO:0006397 | mRNA processing(GO:0006397) |
0.0 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.5 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.0 | 0.0 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.0 | 0.0 | GO:0042160 | plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.0 | 0.3 | GO:0019674 | NAD metabolic process(GO:0019674) |
0.0 | 0.3 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 0.0 | GO:0055069 | cellular zinc ion homeostasis(GO:0006882) zinc ion homeostasis(GO:0055069) |
0.0 | 0.1 | GO:0007099 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.0 | 0.4 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.1 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.0 | 1.1 | GO:0030833 | regulation of actin filament polymerization(GO:0030833) |
0.0 | 0.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.9 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.0 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.3 | GO:0030183 | B cell differentiation(GO:0030183) |
0.0 | 0.0 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.0 | 0.0 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.0 | 0.1 | GO:0051168 | nuclear export(GO:0051168) |
0.0 | 1.7 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 2.2 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 0.0 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.1 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.0 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.0 | 0.1 | GO:0046337 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.3 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 0.1 | GO:0036465 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.1 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.0 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.0 | 0.1 | GO:1904251 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.0 | 1.0 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.0 | GO:0006490 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.3 | GO:0051297 | centrosome organization(GO:0051297) |
0.0 | 0.0 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.0 | 0.1 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.0 | 0.2 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.0 | 0.0 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.0 | GO:1903299 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.1 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.0 | 0.2 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.1 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.0 | 0.1 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.0 | 0.0 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.0 | 0.4 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.0 | 0.2 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 1.7 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.0 | 0.1 | GO:0072666 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.1 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.0 | 0.1 | GO:0043049 | otic placode formation(GO:0043049) |
0.0 | 0.1 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.0 | 0.2 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.0 | 0.1 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.0 | 0.2 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 1.8 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.4 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.1 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
0.0 | 0.1 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.1 | GO:0007031 | peroxisome organization(GO:0007031) |
0.0 | 0.2 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 1.8 | GO:0031497 | chromatin assembly(GO:0031497) |
0.0 | 0.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.7 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.1 | GO:0033363 | secretory granule organization(GO:0033363) |
0.0 | 0.1 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.4 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.0 | 0.0 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.0 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.0 | 1.3 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.3 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.1 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.1 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.0 | 0.1 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.0 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.0 | 0.1 | GO:0090174 | organelle membrane fusion(GO:0090174) |
0.0 | 0.1 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.0 | 0.1 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.1 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.0 | 0.1 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0045329 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.0 | 0.2 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.0 | 0.1 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.0 | 0.6 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.0 | 0.1 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.0 | 0.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.4 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.0 | 0.3 | GO:0031396 | regulation of protein ubiquitination(GO:0031396) |
0.0 | 0.2 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.0 | 0.0 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.0 | 0.2 | GO:0051324 | prophase(GO:0051324) |
0.0 | 0.1 | GO:0001881 | receptor recycling(GO:0001881) |
0.0 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 1.7 | GO:0006184 | obsolete GTP catabolic process(GO:0006184) |
0.0 | 0.0 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.1 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.0 | 1.3 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.1 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.1 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.3 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.0 | 0.1 | GO:0006561 | proline metabolic process(GO:0006560) proline biosynthetic process(GO:0006561) |
0.0 | 0.1 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.0 | GO:0001832 | blastocyst growth(GO:0001832) |
0.0 | 0.0 | GO:0097028 | myeloid dendritic cell differentiation(GO:0043011) dendritic cell differentiation(GO:0097028) |
0.0 | 0.0 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.0 | 0.1 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.0 | 0.1 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.0 | 0.0 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.0 | 0.0 | GO:0034123 | positive regulation of toll-like receptor signaling pathway(GO:0034123) |
0.0 | 0.1 | GO:0051340 | regulation of ligase activity(GO:0051340) |
0.0 | 0.1 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.0 | 0.0 | GO:0010985 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) negative regulation of lipoprotein particle clearance(GO:0010985) |
0.0 | 0.1 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.1 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.0 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.0 | 0.7 | GO:0006399 | tRNA metabolic process(GO:0006399) tRNA aminoacylation for protein translation(GO:0006418) amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.0 | 0.0 | GO:0002883 | hypersensitivity(GO:0002524) regulation of hypersensitivity(GO:0002883) positive regulation of hypersensitivity(GO:0002885) |
0.0 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.0 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.4 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.1 | GO:0000050 | urea cycle(GO:0000050) |
0.0 | 0.0 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.0 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.0 | 1.7 | GO:0051603 | proteolysis involved in cellular protein catabolic process(GO:0051603) |
0.0 | 0.1 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.0 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.0 | 0.0 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.0 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.0 | 0.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.2 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 2.4 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.0 | 0.0 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.1 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.0 | 0.0 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 1.1 | GO:0006281 | DNA repair(GO:0006281) |
0.0 | 0.0 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.0 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.0 | 0.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.2 | GO:1905037 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.0 | 0.3 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
0.0 | 0.0 | GO:0070229 | negative regulation of lymphocyte apoptotic process(GO:0070229) |
0.0 | 0.0 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.0 | 0.2 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.0 | 0.1 | GO:0051904 | pigment granule transport(GO:0051904) |
0.0 | 0.2 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 0.1 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 2.7 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.0 | 0.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 0.0 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.0 | 0.1 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.0 | 0.2 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.0 | GO:0031646 | positive regulation of neurological system process(GO:0031646) positive regulation of transmission of nerve impulse(GO:0051971) |
0.0 | 0.0 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.0 | GO:0031503 | protein complex localization(GO:0031503) |
0.0 | 0.0 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.1 | GO:0009156 | ribonucleoside monophosphate biosynthetic process(GO:0009156) |
0.0 | 0.2 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.0 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 0.0 | GO:0046851 | negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
0.0 | 0.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.0 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 0.1 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.0 | GO:0003351 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.0 | 0.0 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.0 | 0.0 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.0 | 0.0 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.0 | 0.2 | GO:0022613 | ribonucleoprotein complex biogenesis(GO:0022613) |
0.0 | 0.0 | GO:0001510 | RNA methylation(GO:0001510) |
0.0 | 0.0 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.0 | 0.1 | GO:0010506 | regulation of autophagy(GO:0010506) |
0.0 | 0.1 | GO:0034030 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.0 | 0.1 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.0 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
0.0 | 0.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.0 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.0 | 1.1 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.0 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.4 | 1.6 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.4 | 1.2 | GO:0072487 | MSL complex(GO:0072487) |
0.4 | 0.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.4 | 1.5 | GO:0070820 | tertiary granule(GO:0070820) |
0.3 | 4.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 1.7 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 2.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.3 | 1.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.3 | 1.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 0.7 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 0.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 1.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 0.7 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.2 | 1.6 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.2 | 0.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 0.6 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 0.6 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 0.7 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.2 | 1.3 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 0.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 0.5 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 0.5 | GO:0031904 | endosome lumen(GO:0031904) |
0.2 | 1.2 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.2 | 0.8 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 0.7 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.2 | 1.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 0.5 | GO:1903561 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.2 | 1.1 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.2 | 0.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.2 | 1.7 | GO:0071564 | npBAF complex(GO:0071564) |
0.2 | 0.2 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.2 | 1.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 1.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 4.1 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.1 | 0.6 | GO:0031211 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 1.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.9 | GO:0016580 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.1 | 0.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 1.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.3 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 2.3 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.1 | 2.9 | GO:0032155 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.1 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 1.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.5 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.4 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.2 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 1.1 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 1.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 1.0 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.3 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.1 | 0.3 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.2 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 0.2 | GO:0019867 | outer membrane(GO:0019867) |
0.1 | 0.3 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.5 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 1.0 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 1.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.6 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.6 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.3 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.5 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 1.0 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.1 | 1.0 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 5.5 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 3.5 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 1.3 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.6 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.1 | 0.3 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.4 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 6.3 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.3 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.1 | 0.2 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.2 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 0.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.1 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.1 | 0.4 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.1 | 0.2 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.1 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 4.2 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.7 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 1.7 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.3 | GO:0033185 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 2.0 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 7.9 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 0.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.4 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.1 | 0.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.2 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.6 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.3 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 1.4 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 1.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.2 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.1 | 1.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.3 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 1.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 2.6 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.9 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 1.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.5 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.1 | 0.2 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.1 | 0.7 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 1.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 0.3 | GO:0097526 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.1 | 1.4 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 1.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.1 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 2.3 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 1.7 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.4 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.1 | 0.4 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 1.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.2 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.1 | 3.6 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.9 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.6 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.2 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.4 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.2 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 0.8 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 0.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 2.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.1 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.1 | 0.3 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 1.1 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.1 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.7 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.4 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.3 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.7 | GO:0034708 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.1 | 0.2 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 2.2 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 2.2 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 0.8 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 4.5 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 7.0 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.4 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.1 | 0.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 1.3 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.1 | 1.2 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.1 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.2 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.3 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 0.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.0 | GO:0042827 | platelet dense granule(GO:0042827) |
0.0 | 0.8 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.1 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.0 | 1.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 3.2 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.1 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 0.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 1.5 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 2.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 2.3 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 5.0 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.7 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 0.0 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 0.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.2 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 2.8 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.5 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.2 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.4 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.0 | 0.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 1.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.3 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 2.0 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.0 | 0.0 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.0 | 0.6 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
0.0 | 0.5 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.4 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.4 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 2.7 | GO:0005819 | spindle(GO:0005819) |
0.0 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.1 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 0.1 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.3 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.2 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.0 | 0.1 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.9 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 1.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.3 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 1.0 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.4 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.4 | GO:1902493 | histone acetyltransferase complex(GO:0000123) protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.0 | 0.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.3 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
0.0 | 0.7 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 1.3 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.0 | 0.2 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.2 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.0 | 0.6 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.4 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.3 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.0 | 3.6 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 2.1 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 1.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.2 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.0 | 3.5 | GO:0005768 | endosome(GO:0005768) |
0.0 | 1.1 | GO:0005840 | ribosome(GO:0005840) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 1.5 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.1 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.2 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 1.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.7 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 4.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.4 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.0 | 4.8 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.0 | 0.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.1 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.0 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 35.8 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 0.2 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 2.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.2 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.0 | 0.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 0.2 | GO:0098552 | side of membrane(GO:0098552) |
0.0 | 0.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.2 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 1.0 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.1 | GO:0033011 | perinuclear theca(GO:0033011) |
0.0 | 15.7 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 1.3 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 1.6 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 9.5 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.0 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.0 | 1.1 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.1 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.0 | 0.5 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.0 | 0.6 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.2 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 0.1 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 3.0 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 5.8 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.1 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.3 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 0.1 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 31.0 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 1.0 | GO:0045095 | keratin filament(GO:0045095) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.5 | 1.5 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.5 | 1.4 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.3 | 1.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.3 | 1.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.3 | 1.7 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.3 | 1.9 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.3 | 5.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 1.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 1.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 1.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.3 | 1.7 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 1.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 0.8 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.3 | 0.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 1.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.3 | 0.8 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.2 | 0.7 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 0.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 1.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 0.7 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.2 | 0.7 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 0.7 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 0.9 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 1.4 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 4.1 | GO:0043621 | protein self-association(GO:0043621) |
0.2 | 0.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 0.8 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 2.9 | GO:0005035 | death receptor activity(GO:0005035) |
0.2 | 0.6 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 0.6 | GO:0034648 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.2 | 1.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 1.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 0.6 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 1.7 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 0.6 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 1.8 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 0.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 0.5 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.2 | 0.5 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.2 | 1.0 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 0.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 0.5 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 0.5 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.2 | 8.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 0.2 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.2 | 1.3 | GO:0030371 | translation repressor activity(GO:0030371) |
0.2 | 0.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 1.9 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 0.5 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.2 | 0.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 6.1 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.1 | 0.6 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 2.4 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.1 | 0.4 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.4 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.6 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.4 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.1 | 0.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.4 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 0.6 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 5.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 1.0 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 0.6 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 0.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.8 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 2.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 1.1 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.1 | 0.4 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.9 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.9 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.4 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.4 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.1 | 1.3 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 0.4 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 0.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.4 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 0.4 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 1.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.4 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.7 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.5 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.7 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 0.4 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 1.2 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 1.0 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 2.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.6 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.1 | 0.5 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.4 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.1 | 0.9 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.5 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.5 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.9 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.8 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 0.3 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.4 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 2.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.5 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.1 | 0.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 1.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 1.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 1.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.4 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.6 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.1 | 1.3 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 0.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 3.2 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.3 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.1 | 0.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 0.3 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 0.5 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.1 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 0.7 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 1.7 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.3 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 1.2 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.1 | 0.5 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
0.1 | 0.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.3 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.4 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 0.2 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 0.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 1.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.4 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.8 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 2.3 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 1.1 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.4 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.7 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.3 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.1 | 1.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.3 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.1 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.3 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.5 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 0.3 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.7 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.2 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.1 | 1.4 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 0.9 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.1 | 0.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.7 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.3 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.1 | 0.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.4 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.5 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 0.4 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 3.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.1 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 1.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.8 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.1 | 0.5 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 0.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 1.0 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 3.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.5 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.4 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.3 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 0.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.5 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.1 | GO:0000739 | obsolete DNA strand annealing activity(GO:0000739) |
0.1 | 2.1 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.1 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.1 | 0.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 0.4 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 1.1 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.1 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.8 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 1.0 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 1.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.4 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 1.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.2 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.1 | 0.7 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.3 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.3 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.1 | 0.2 | GO:0004803 | transposase activity(GO:0004803) |
0.1 | 0.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.4 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.3 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.3 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.6 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.1 | 0.3 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.1 | 0.5 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 1.0 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 1.7 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.3 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.2 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.3 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.1 | 0.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.5 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.3 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.3 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.1 | 0.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.4 | GO:0061659 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 1.3 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 2.8 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.5 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 1.1 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 1.3 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 1.4 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.2 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.1 | 0.4 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.2 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.5 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 1.4 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 0.2 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 1.5 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.1 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.2 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 0.5 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.1 | 0.4 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.8 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 0.1 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.1 | 0.2 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.1 | 0.2 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.1 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 2.2 | GO:0050136 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.7 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 0.8 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.1 | 0.3 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 4.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.2 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.1 | 0.2 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.2 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 1.2 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.1 | 0.2 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 1.0 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 2.6 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 0.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.3 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.1 | 0.1 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.1 | 0.2 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 0.2 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.1 | 0.5 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.1 | 1.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.1 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 0.3 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.2 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.2 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.1 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.2 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.3 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 0.6 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 0.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 1.2 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.8 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 5.1 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.1 | 0.4 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.3 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.2 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.0 | 5.3 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.0 | 0.2 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.2 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.0 | 0.9 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.5 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.4 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.3 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 3.3 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.7 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.0 | 0.2 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.0 | 2.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 1.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.1 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.0 | 0.9 | GO:0036459 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.3 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 0.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.3 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.2 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.1 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.0 | 0.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.1 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.5 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.2 | GO:0032451 | demethylase activity(GO:0032451) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 1.5 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.7 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.3 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 0.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.2 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.3 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 1.3 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.4 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 0.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 4.4 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.3 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.2 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.4 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.1 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.0 | 0.4 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.0 | 0.0 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.0 | 0.5 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.2 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 0.6 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.2 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
0.0 | 0.4 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.2 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.0 | 0.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 4.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.4 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.0 | 1.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 1.0 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.0 | 0.3 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.1 | GO:0060229 | lipase activator activity(GO:0060229) |
0.0 | 0.1 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 2.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.8 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.0 | 0.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.2 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.6 | GO:0019829 | cation-transporting ATPase activity(GO:0019829) |
0.0 | 0.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.2 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 0.2 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.0 | 0.4 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 9.6 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 0.5 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.4 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 4.2 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.1 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.5 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.0 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.0 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.8 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.0 | 0.2 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.0 | GO:0015923 | mannosidase activity(GO:0015923) |
0.0 | 0.3 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.0 | GO:0045569 | TRAIL binding(GO:0045569) |
0.0 | 2.9 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.0 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.0 | 2.5 | GO:0016874 | ligase activity(GO:0016874) |
0.0 | 1.8 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.0 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.2 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.3 | GO:0005343 | organic acid:sodium symporter activity(GO:0005343) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.3 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.0 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.1 | GO:0046527 | UDP-glucosyltransferase activity(GO:0035251) glucosyltransferase activity(GO:0046527) |
0.0 | 0.3 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.0 | 0.0 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.0 | 0.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.1 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 0.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.0 | GO:0016531 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
0.0 | 0.1 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.0 | 0.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.0 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.0 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.2 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.0 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.2 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
0.0 | 0.1 | GO:0080032 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.6 | GO:0016829 | lyase activity(GO:0016829) |
0.0 | 0.1 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.1 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.0 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.1 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.0 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.0 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.1 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.0 | 0.1 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.0 | 0.1 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 0.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.3 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.1 | GO:0016853 | isomerase activity(GO:0016853) |
0.0 | 0.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.0 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 20.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.3 | 3.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 4.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.3 | 4.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 6.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 2.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.2 | 0.9 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 4.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 0.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 1.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 1.5 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 1.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 7.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 5.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 3.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 1.3 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 2.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 2.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 2.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 4.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 3.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 0.5 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 0.5 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 1.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 2.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 1.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 3.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 3.4 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 2.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 2.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 1.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 0.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 1.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.2 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.4 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 1.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 2.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 1.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 3.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 0.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 1.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 3.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.8 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.5 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 2.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 1.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 1.6 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 3.0 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 1.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.3 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 2.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 2.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.9 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 1.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 1.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.4 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 1.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 1.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.2 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 0.8 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.6 | 1.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.5 | 0.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.5 | 6.1 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.4 | 0.4 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.4 | 7.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.4 | 0.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 0.3 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.3 | 5.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 0.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 3.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 0.2 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.2 | 1.7 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 3.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 1.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 2.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 4.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 7.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 0.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 2.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 1.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 1.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 1.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 7.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 2.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 0.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.1 | 3.3 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 4.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 2.5 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 1.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 1.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 2.0 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.3 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.1 | 1.9 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 3.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.8 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 0.5 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 3.3 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 0.7 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 4.8 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.1 | 1.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 1.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 1.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 0.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 2.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.0 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 0.1 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 3.7 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 1.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 1.5 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 1.2 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.1 | 0.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 0.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 2.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 4.6 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.1 | 0.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 1.0 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 0.5 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 1.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 1.9 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 2.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 1.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.8 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 1.6 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 1.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 1.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 2.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 0.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 0.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 0.5 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 0.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 1.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 1.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 1.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 1.1 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 0.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 0.1 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.1 | 0.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 2.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 0.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 1.4 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 1.2 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 1.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.7 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.8 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 6.2 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 0.2 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.1 | 0.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 1.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 0.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 4.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 1.1 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.1 | 1.0 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 0.7 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 7.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.9 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 1.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 3.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 0.5 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 1.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.9 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.1 | 0.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 0.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 3.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.1 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 0.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 1.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 1.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 1.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.7 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.1 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 1.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.1 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.0 | 0.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 2.2 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.5 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 1.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.3 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.0 | 0.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.4 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.0 | 0.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.3 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.4 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.2 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.2 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.0 | 0.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.9 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.0 | 1.5 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.3 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 2.5 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.2 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 0.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.1 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.3 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 1.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 1.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.6 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.0 | 0.9 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.6 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 1.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.1 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.0 | 0.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.0 | 0.8 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.4 | REACTOME CELL CYCLE MITOTIC | Genes involved in Cell Cycle, Mitotic |
0.0 | 0.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 1.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.6 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.1 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.1 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.0 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.0 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.0 | 0.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.1 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 0.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 3.7 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.1 | REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION | Genes involved in Post-translational protein modification |